BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12698959)

  • 1. [What are the sequelae of the ALLHAT Study?].
    Vetter W;
    Dtsch Med Wochenschr; 2003 Mar; 128(13):687. PubMed ID: 12698959
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
    Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study].
    Schillaci G; Verdecchia P
    Ital Heart J Suppl; 2000 Sep; 1(9):1215-7. PubMed ID: 11140297
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Whelton PK; Barzilay J; Cushman WC; Davis BR; Iiamathi E; Kostis JB; Leenen FH; Louis GT; Margolis KL; Mathis DE; Moloo J; Nwachuku C; Panebianco D; Parish DC; Pressel S; Simmons DL; Thadani U;
    Arch Intern Med; 2005 Jun; 165(12):1401-9. PubMed ID: 15983290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the ALLHAT trial: is the debate about initial antihypertensive drug therapy over?
    Moser M
    J Clin Hypertens (Greenwich); 2003; 5(1):5-8. PubMed ID: 12556646
    [No Abstract]   [Full Text] [Related]  

  • 9. The ALLHAT report: a case of information and misinformation.
    Weber MA
    J Clin Hypertens (Greenwich); 2003; 5(1):9-13. PubMed ID: 12556647
    [No Abstract]   [Full Text] [Related]  

  • 10. ALLHAT: what has it taught us so far?
    Leenen FH
    CMAJ; 2004 Sep; 171(7):719-20. PubMed ID: 15451829
    [No Abstract]   [Full Text] [Related]  

  • 11. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
    Einhorn PT; Davis BR; Massie BM; Cushman WC; Piller LB; Simpson LM; Levy D; Nwachuku CE; Black HR;
    Am Heart J; 2007 Jan; 153(1):42-53. PubMed ID: 17174636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amlodipine or lisinopril was not better than chlorthalidone in lowering CHD risk in hypertension.
    Heckman GA; Psaty BM
    ACP J Club; 2003; 139(3):A15; author reply A15. PubMed ID: 14594435
    [No Abstract]   [Full Text] [Related]  

  • 13. Hats off to an old blood pressure drug. For treating high blood pressure, an old--and inexpensive--medication is a great place to start or a good one to add.
    Harv Heart Lett; 2003 Mar; 13(7):1-2. PubMed ID: 12654580
    [No Abstract]   [Full Text] [Related]  

  • 14. [Old or new antihypertensive drugs? Consequences from ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial].
    Düsing R
    Dtsch Med Wochenschr; 2003 Jan; 128(5):214-6. PubMed ID: 12557115
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT.
    Bangalore S; Davis BR; Cushman WC; Pressel SL; Muntner PM; Calhoun DA; Kostis JB; Whelton PK; Probstfield JL; Rahman M; Black HR;
    Am J Med; 2017 Apr; 130(4):439-448.e9. PubMed ID: 27984005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ALLHAT: Old Hat Hits All? On selection of the optimal antihypertensive drug].
    Slany J
    Wien Klin Wochenschr; 2003 Mar; 115(5-6):149-51. PubMed ID: 12741071
    [No Abstract]   [Full Text] [Related]  

  • 17. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.
    Wang JG; Yan P; Jeffers BW
    J Am Soc Hypertens; 2014 May; 8(5):340-9. PubMed ID: 24685006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic Prevention of Incident Atrial Fibrillation: Long-Term Results From the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Dewland TA; Soliman EZ; Yamal JM; Davis BR; Alonso A; Albert CM; Simpson LM; Haywood LJ; Marcus GM
    Circ Arrhythm Electrophysiol; 2017 Dec; 10(12):. PubMed ID: 29212812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALLHAT finds diuretics best for initial hypertension therapy.
    Traynor K
    Am J Health Syst Pharm; 2003 Feb; 60(3):222, 224. PubMed ID: 12613228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.